/AROW

Arrow Financial Corp

AROW

$39.15USD↑+0.20%+0.08 today

MARKET CAP

725.2M

P/E (TTM)

14.8x

FWD P/E

—

DAY RANGE

$39 – $40

52W RANGE

$26

$43

AI Summary

Stalk

StalkMedium

AROW is in a Stage 2 advancing regime with a bullish medium-term bias reinforced by an active Momentum Breakout pattern and intact higher highs and higher lows. However, price is extended significantly above the rising 9- and 20-EMAs and sits in extreme overbought territory on RSI and options score, so we defer execution. We will stalk a pullback into the rising EMA support zone and seek price acceptance before participating in the next uptrend leg. Key risks include deeper retracements from overbought conditions, failure to hold EMA support, and potential momentum fade ahead of Stage transition.

↑Earnings yield of 1.59 indicates attractive valuation versus peers.
↑Book-to-price ratio near 1.01 suggests fair pricing relative to book value.
↓Negative growth and earnings revision factors signal faltering expansion.

Full analysis →

Buying

5

institutions

Selling

2

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.40 M	57.38 M	+148.53 K	+36.6%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	186.72 K	7.65 M	+-43.56 K	-1.0%	0.01%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	120.71 K	4.95 M	+407.00	+22.5%	0.01%
AC Aqr Capital Management LLC Q2 2026	BUY	116.80 K	4.79 M	+19.78 K	+47.0%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	59.19 K	2.43 M	+40.15 K	+279.6%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	7.77 K	319.54 K	+793.00	+37.4%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-49.79 K	-100.0%	0.00%